Stabilized Hematoxylin Composition for Automated Staining
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Hematoxylin staining solutions for biological samples face instability issues due to changes in hematein concentration over time, leading to staining inconsistencies, particularly in automated processes where visual adjustments are costly and disruptive.
Innovation Solution
A stabilized hematoxylin composition is developed, including a solvent, hematoxylin, a chemical oxidant to convert hematoxylin to hematein, a mordant, cyclodextrin, and hydroquinone, which enhances stability and maintains effective dye concentration for consistent staining.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If chemical oxidant is used to accelerate conversion of hematoxylin to hematein, then staining speed is improved, but solution stability deteriorates due to faster degradation
Solution Approach 1:
The patent changes the chemical parameters of the solution by adding specific stabilizing agents (sulfite, bisulfite, or dithionite) that alter the oxidation-reduction balance. These agents donate electrons to hematein, preventing its over-oxidation to degraded products, thereby maintaining solution stability while allowing accelerated conversion to proceed
Solution Approach 2:
The stabilizing agents (sulfite, bisulfite, or dithionite) act as intermediary substances that mediate between the chemical oxidant and hematein. They provide a controlled electron transfer mechanism that prevents direct over-oxidation of hematein, serving as a protective intermediary layer in the chemical reaction system
2Manufacturing precision
If visual inspection is used to compensate for hematein concentration changes, then staining consistency is improved, but device complexity and cost increase due to imaging equipment requirements
Solution Approach 1:
The hematoxylin solution becomes self-regulating through the inclusion of stabilizing agents that automatically maintain hematein concentration within an effective range. The solution self-corrects for concentration changes over time without requiring external monitoring or adjustment, making the system self-sufficient and eliminating the need for complex imaging equipment
Solution Approach 2:
The patent extracts and eliminates the need for complex imaging and monitoring equipment by fundamentally stabilizing the chemical composition. Instead of adding complex detection systems to compensate for instability, the solution itself is made stable through chemical modification, removing the harmful dependency on expensive equipment
3Ease of operation
If hematein concentration is allowed to change over time, then manual adjustment is possible, but productivity decreases due to extended processing time and sample reprocessing
Solution Approach 1:
The stabilizing agents ensure continuous maintenance of effective hematein concentration throughout the solution's shelf life and during use. This continuous stability eliminates interruptions, reprocessing steps, and time losses associated with concentration variability, enabling continuous high-throughput processing in automated systems
Solution Approach 2:
The stabilizing agents are incorporated into the solution during preparation, performing preliminary stabilization action before the solution is put into use. This advance preparation ensures that the solution maintains optimal staining characteristics from the first use through its entire lifespan, preventing future consistency issues
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The stabilized composition provides improved stability and darker staining of biological samples, especially in automated methods, reducing the need for costly imaging and minimizing processing disruptions by maintaining hematein concentration over time.
Implementation Method 1
an oxidation product of hematoxylin, hematein, becomes the active staining component
Implementation Method 2
both of cyclodextrin and hydroquinone
Implementation Method 3
both of cyclodextrin and hydroquinone
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A stabilized hematoxylin composition is disclosed that includes one or both of a host compound and an antioxidant. The disclosed composition exhibits sufficient stability to be utilized in an automated staining process without undue degradation prior to use of the composition to stain a biological sample. Methods of using and making the stabilized composition also are disclosed.